EDAP, Duke Restart Ablatherm-HIFU Localized Prostate Cancer Clinical Study
This technology offers an alternative to other approved therapies for prostate cancer and may be effective in selected individuals as a primary therapy.
|
New Prostate Cancer Treatment Wins Operations Research Award
The unique application of operations research to the treatment of prostate cancer allowed Memorial Sloan-Kettering Cancer Center to better Fortune 500 companies and win an international competition for best project by an organization.
|
Better Blood Test for Prostate Cancer
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.
|
Quality Of Life After Common Treatments For Prostate Cancer
A rigorous study of quality of life in patients who underwent one of three common prostate cancer treatments found that each treatment affected men's lives in different ways.
|
New Blood Test For Prostate Cancer Better Detects The Disease
A new prostate cancer research has been published by Onconome, Inc., which conducted a breakthrough prostate cancer study at The Johns Hopkins School of Medicine.
|
FDA Accepts Satraplatin NDA For Filing And Grants Priority Review Status
FDA has accepted for filing the Company's New Drug Application for satraplatin in combination with prednisone for patients with hormone-refractory prostate cancer whose prior chemotherapy has failed.
|
Imaging method shows if treatment for advanced prostate cancer is working
Researchers have identified a new imaging technique that can measure the effectiveness of treatment for prostate cancer that has spread to the bones.
|
PSA doubling predicts prostate cancer recurrence
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy.
|
Significant Prostate Cancer Risk Factors Identified
A study has identified seven genetic risk factors-DNA sequences carried by some people but not others-that predict risk for prostate cancer.
|
FDA Committee Reviewed Provenge for Hormone Refractory Prostate Cancer
There is substantial evidence of efficacy and safety of PROVENGE (sipuleucel-T) for the treatment of patients with asymptomatic, metastatic, androgen-independent (also known as hormone refractory) prostate cancer.
|
Multiple genetic risk factors for prostate cancer
Seven genetic risk factors predict risk for prostate cancer, including DNA sequences carried by some people but not others.
|
Two New Studies Test Varying Treatments for Enlarged Prostate
Unpleasant urinary symptoms caused by an enlarged prostate are also known as benign prostatic hyperplasia (BPH).
|
Age-Specific PSA Cut-Offs Avoid Unnecessary Prostate Biopsies in Older Men
The introduction of age-specific cut-offs for prostate-specific antigen (PSA) levels used in prostate cancer screening will reduce the number of unnecessary prostate biopsies in older men who naturally have higher levels of PSA than younger men.
|
Links Between Prostate Cancer Treatment, Periodontal Disease
Androgen deprivation therapy (ADT) has become a valuable weapon in the fight against prostate cancer.
|
Biopsy May Underestimate Prostate Cancer in Obese and Overweight Men
Obese and overweight men who are diagnosed with prostate cancer by biopsy are more likely than healthy weight men to actually have a more aggressive case of the disease than the biopsy results would indicate.
|
Soy is protective against localized prostate cancer
Soy offers no protection against advanced prostate cancer.
|
Health-care inequities underscore racial disparities in prostate cancer
Improving access to healthcare system may benefit African-American prostate cancer patients more than educational or motivational interventions, according to a new study.
|
Health disparities in prostate cancer stem from lack of care
Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than increased education about the disease.
|
Tea Antioxidant Plus Celebrex May Fight Prostate Cancer
A component of green tea, combined with low doses of the cox2 inhibitor painkiller Celebrex, may be able to slow prostate cancer growth.
|
Prostate Brachytherapy Causes Fewer Side Effects Than Surgery
Men with prostate cancer have a slightly better long-term side effects profile with radiation seed implants than they do with surgery.
|
Prostate cancer therapy may increase risk of death from heart disease in older men
Androgen deprivation therapy, one of the most common treatments for prostate cancer, may increase the risk of death from heart disease in patients over age 65.
|
Prostate Cancer Patients See High Survival Rates with Seed Implants
The patients received the seed implants as the sole treatment for prostate cancer with no additional chemotherapy or radiation therapy.
|
Sunshine pill for prostate cancer in 2009
A tablet designed to emulate the healing power of the sun could be available for the treatment of advanced prostate cancer as early as 2009.
|
Worried about prostate cancer? Tomato-broccoli combo shown to be effective
Tomatoes and broccoli, two vegetables known for their cancer fighting qualities, are better at shrinking prostate tumors when both are part of the daily diet than when they're eaten alone.
|
The risk of dying from prostate cancer increased by excess weight
The risk of dying from prostate cancer is higher if you have excess weight or as an adult you gain weight. Obesity increases the risk of death from prostate cancer.
|
Hair-Loss Drug Impedes Prostate Cancer Detection in Middle-Aged Men
The prostate specific antigen cancer screening test is falsely lowered by a factor of two in middle aged men who have taken Propecia.
|
Role for Y Chromosome in Prostate Cancer, Study Suggests
Among a group of men in Israel, men with only daughters had a 40 percent higher risk of prostate cancer than men with at least one son.
|
Reduced Prostate Cancer Risk Is Linked To Weight Loss
Study of 70,000 men finds men who lose weight may reduce their risk of prostate cancer.
|
Prostate cancer treatment is associated with long-term financial costs
The financial burden related to prostate cancer management over five years is substantial and sustained.
|
Treating Prostate Cancer In Elderly Men - Longer Survival
Elderly men who received treatment for localized prostate cancer survived significantly longer than men who did not receive treatment.
|
Prescribing inconsistencies in prostate cancer treatment in the UK
84 percent of GPs and 76 percent of specialists agree that there is a significant legal risk associated with off label prescribing in prostate cancer when there is a licensed alternative available.
|
Older men treated for early prostate cancer live longer than those who are not
Men who received prostate cancer treatment were 31 percent less likely to die.
|
Family History of Prostate Cancer More Likely in African-Americans With Prostate Cancer
African Americans with prostate cancer more likely to have family history of prostate, breast cancer.
|
Prostate Cancer and Association With Plasma Cholesterol
Men experienced half the risk of developing advanced prostate cancer when using statin drugs.
|
Increased Patient Demand for Prostate Test Has Serious Implications for Cancer Services
Male patients are increasingly demanding PSA tests for prostate cancer, despite lack of evidence that they are effective.
|
A PSA-Activated Protoxin That Kills Prostate Cancer
Using a protein made by prostate cancer scientists have found a way to target and kill the cancer cells themselves.
|
'Muscle' Protein Drives Prostate Cancer
Myosin VI may be critical in starting and maintaining the malignant properties of the majority of human prostate cancers diagnosed today.
|
Scientists Discover Way To Block Growth of Prostate Cancer Cells
The hope is that a drug could be used eventually for prostate cancer treatment in men at high risk of developing prostate cancer and to prevent recurrences in men already treated for primary tumours.
|
Researchers Studying Novel Therapy For Prostate Cancer
The University of Iowa therapeutic trial may lead to new treatments for men diagnosed with prostate cancer.
|
Largest Genome-Wide Study Of Prostate Cancer in African American Men
Collaborative effort may open doors to improved diagnosis and treatment of prostate cancer.
|
